Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OLOPATADINE HYDROCHLORIDE
- Azelastine Allergen Chamber - Onset of Action Study
- Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment
- A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
- Efficacy and Safety of Fixed Dose Combination (FDC) of Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Molo; Also Referred as GSP 301) in the Treatment of Seasonal Allergic Rhinitis (SAR)
- Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic Conjunctivitis
- Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR)
- Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)
- Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects
- Effectiveness of Olopatadine HCl Ophthalmic Solution for the Treatment of Allergic Conjunctivitis in Japan
- AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
- A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
- Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients
- Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic Conjunctivitis
- Comparing Patient Satisfaction With Pataday or Bepreve
- Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)
- Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
- Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis
- Safety and Comfort of AL-4943A Ophthalmic Solution
- A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.
- A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
- Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis
- Patient Perceptions and Quality of Life Associated With the Use of Olapatadine 0.2% for the Treatment of Allergic Conjunctivitis
- Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis
- Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric Patients
- An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to Placebo
- An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis
- Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms
- Study of Olopatadine HCl Ophthalmic Solutions Compared to Vehicle Using the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis in Japanese Subjects
- Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis
- Comparison of Seasonal Allergic Rhinitis Treatment With 2 Antihistamines Used in Combination With Intranasal Corticosteroid
- Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis
- Efficacy Investigation Study of Olopatadine Hydrochloride Ophthalmic Solution Using OHIO Chamber in Patients With Seasonal Allergic Rhinitis (SAR)
- Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
- Olopatadine Eye Drops and Allergy Skin Testing
- Evaluation of the Sensory Attributes of Olopatadine 0.6% and Azelastine 137mcg Nasal Sprays in Patients w/Allergic Rhinitis
- Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial
- A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
- Effect of Olopatadine on Allergic Tear Mediators
- Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
- Safety Study of Olopatadine Nasal Spray
- Comparison of CL Wear Between Two Allergy Drops
- Mast-Cell Stabilizing Effects of Olopatadine
- Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
Clinical trials list
click for details